NICE clinical guidelines
Issued: May 2008
CG67
Lipid modification: Cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease
This is an extract from the guidance and may be misleading if read alone. The complete guidance is available at guidance.nice.org.uk/cg67
Important information about this guidance
In February 2010 NICE Guidance Executive agreed to withdraw the recommendation that the Framingham risk equation should be the equation of choice for assessment of CVD risk, but agreed that it should be considered as one of the possible equations to use. Recommendations relating specifically to the use and modification of the Framingham risk equation have been moved to appendix D. Consider these recommendations when using the Framingham risk equation for assessment of CVD risk.